Eribulin Mesylate in the management of metastatic breast cancer and other solid cancers: a drug review.

Auteurs : Polastro L, Aftimos P, Awada A
Jaar : 2014
Journal : Expert Rev Anticancer Ther
Volume : 14(6)
Pagina's : 649-65